CN111214441B - 一种古罗糖醛酸低聚糖脂质体及其制备方法 - Google Patents
一种古罗糖醛酸低聚糖脂质体及其制备方法 Download PDFInfo
- Publication number
- CN111214441B CN111214441B CN202010185114.3A CN202010185114A CN111214441B CN 111214441 B CN111214441 B CN 111214441B CN 202010185114 A CN202010185114 A CN 202010185114A CN 111214441 B CN111214441 B CN 111214441B
- Authority
- CN
- China
- Prior art keywords
- liposome
- guluronic acid
- acid oligosaccharide
- suspension
- tween
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000002502 liposome Substances 0.000 title claims abstract description 122
- 229920001542 oligosaccharide Polymers 0.000 title claims abstract description 100
- -1 Guluronic acid oligosaccharide Chemical class 0.000 title claims abstract description 96
- AEMOLEFTQBMNLQ-UHFFFAOYSA-N beta-D-galactopyranuronic acid Natural products OC1OC(C(O)=O)C(O)C(O)C1O AEMOLEFTQBMNLQ-UHFFFAOYSA-N 0.000 title claims abstract description 95
- 238000002360 preparation method Methods 0.000 title claims abstract description 14
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims abstract description 24
- 239000000725 suspension Substances 0.000 claims abstract description 19
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims abstract description 14
- 229920000053 polysorbate 80 Polymers 0.000 claims abstract description 14
- 235000012000 cholesterol Nutrition 0.000 claims abstract description 12
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims abstract description 8
- 235000010445 lecithin Nutrition 0.000 claims abstract description 8
- 239000000787 lecithin Substances 0.000 claims abstract description 8
- 229940067606 lecithin Drugs 0.000 claims abstract description 8
- 238000009210 therapy by ultrasound Methods 0.000 claims abstract description 7
- 239000012528 membrane Substances 0.000 claims description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 15
- 238000000034 method Methods 0.000 claims description 9
- 239000003960 organic solvent Substances 0.000 claims description 9
- 239000008367 deionised water Substances 0.000 claims description 6
- 229910021641 deionized water Inorganic materials 0.000 claims description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical group CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 4
- 238000001704 evaporation Methods 0.000 claims description 3
- 230000008020 evaporation Effects 0.000 claims description 2
- 238000000527 sonication Methods 0.000 claims description 2
- 239000002245 particle Substances 0.000 abstract description 18
- 230000001737 promoting effect Effects 0.000 abstract description 5
- 238000000265 homogenisation Methods 0.000 abstract description 4
- 230000001900 immune effect Effects 0.000 abstract description 2
- 239000000243 solution Substances 0.000 description 15
- 230000000694 effects Effects 0.000 description 11
- 210000004027 cell Anatomy 0.000 description 7
- 239000003814 drug Substances 0.000 description 7
- 210000002540 macrophage Anatomy 0.000 description 7
- 235000010443 alginic acid Nutrition 0.000 description 6
- 229920000615 alginic acid Polymers 0.000 description 6
- 229940079593 drug Drugs 0.000 description 6
- 238000005538 encapsulation Methods 0.000 description 6
- 230000003833 cell viability Effects 0.000 description 5
- 230000028327 secretion Effects 0.000 description 5
- 238000003860 storage Methods 0.000 description 5
- 150000002482 oligosaccharides Chemical class 0.000 description 4
- 239000012086 standard solution Substances 0.000 description 4
- 238000002835 absorbance Methods 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 238000007865 diluting Methods 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 238000002604 ultrasonography Methods 0.000 description 3
- ZCUQOPGIJRGJDA-UHFFFAOYSA-N 1-naphthalen-1-ylethane-1,2-diamine Chemical compound C1=CC=C2C(C(N)CN)=CC=CC2=C1 ZCUQOPGIJRGJDA-UHFFFAOYSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 238000004115 adherent culture Methods 0.000 description 2
- 239000003012 bilayer membrane Substances 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 239000002158 endotoxin Substances 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 230000031700 light absorption Effects 0.000 description 2
- 229920006008 lipopolysaccharide Polymers 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000000108 ultra-filtration Methods 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- AEMOLEFTQBMNLQ-AZLKCVHYSA-N (2r,3s,4s,5s,6r)-3,4,5,6-tetrahydroxyoxane-2-carboxylic acid Chemical compound O[C@@H]1O[C@@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H]1O AEMOLEFTQBMNLQ-AZLKCVHYSA-N 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- AEMOLEFTQBMNLQ-BZINKQHNSA-N D-Guluronic Acid Chemical compound OC1O[C@H](C(O)=O)[C@H](O)[C@@H](O)[C@H]1O AEMOLEFTQBMNLQ-BZINKQHNSA-N 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000013270 controlled release Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000012091 fetal bovine serum Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000005965 immune activity Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 238000001000 micrograph Methods 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- OQUKIQWCVTZJAF-UHFFFAOYSA-N phenol;sulfuric acid Chemical compound OS(O)(=O)=O.OC1=CC=CC=C1 OQUKIQWCVTZJAF-UHFFFAOYSA-N 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000001878 scanning electron micrograph Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- NVBFHJWHLNUMCV-UHFFFAOYSA-N sulfamide Chemical compound NS(N)(=O)=O NVBFHJWHLNUMCV-UHFFFAOYSA-N 0.000 description 1
- FDDDEECHVMSUSB-UHFFFAOYSA-N sulfanilamide Chemical compound NC1=CC=C(S(N)(=O)=O)C=C1 FDDDEECHVMSUSB-UHFFFAOYSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 238000013268 sustained release Methods 0.000 description 1
- 239000012730 sustained-release form Substances 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (6)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010185114.3A CN111214441B (zh) | 2020-03-16 | 2020-03-16 | 一种古罗糖醛酸低聚糖脂质体及其制备方法 |
PCT/CN2020/081269 WO2021184405A1 (zh) | 2020-03-16 | 2020-03-26 | 一种古罗糖醛酸低聚糖脂质体、其制备方法、其促免疫活性的用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010185114.3A CN111214441B (zh) | 2020-03-16 | 2020-03-16 | 一种古罗糖醛酸低聚糖脂质体及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN111214441A CN111214441A (zh) | 2020-06-02 |
CN111214441B true CN111214441B (zh) | 2021-06-08 |
Family
ID=70813279
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010185114.3A Active CN111214441B (zh) | 2020-03-16 | 2020-03-16 | 一种古罗糖醛酸低聚糖脂质体及其制备方法 |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN111214441B (zh) |
WO (1) | WO2021184405A1 (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111658613B (zh) * | 2020-07-13 | 2021-02-09 | 深圳大学 | 一种w/o/w型不饱和古罗糖醛酸纳米乳及其制备方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1207300C (zh) * | 2003-09-01 | 2005-06-22 | 中国海洋大学 | 一种组合低聚糖及其制备方法和应用 |
CN1219786C (zh) * | 2003-11-22 | 2005-09-21 | 中国海洋大学 | 利用芬顿反应制备古罗糖醛酸寡糖的方法 |
FR2939799B1 (fr) * | 2008-12-11 | 2011-03-11 | Sederma Sa | Composition cosmetique comprenant des oligoglucuronanes acetyles. |
CN103536534B (zh) * | 2013-09-29 | 2014-12-10 | 南京农业大学 | 一种地黄多糖脂质体的制备方法 |
CN104814506B (zh) * | 2015-05-14 | 2018-07-10 | 中国计量学院 | 一种以褐藻胶寡糖脂质体为主要成分的虾仁无磷保水剂 |
CN104814929A (zh) * | 2015-05-14 | 2015-08-05 | 中国计量学院 | 一种褐藻胶寡糖脂质体的制备方法 |
CN105343121B (zh) * | 2015-09-28 | 2018-07-06 | 青岛海洋生物医药研究院股份有限公司 | 聚古罗糖醛酸硫酸酯在制备抗乙型肝炎病毒的药物中的应用 |
-
2020
- 2020-03-16 CN CN202010185114.3A patent/CN111214441B/zh active Active
- 2020-03-26 WO PCT/CN2020/081269 patent/WO2021184405A1/zh active Application Filing
Non-Patent Citations (1)
Title |
---|
褐藻胶寡糖纳米脂质体的制备及其生物学功能研究;张转转;《中国优秀硕士学位论文全文数据库工程科技I辑》;20170430;全文 * |
Also Published As
Publication number | Publication date |
---|---|
CN111214441A (zh) | 2020-06-02 |
WO2021184405A1 (zh) | 2021-09-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109288819B (zh) | 一种含槲皮素和益生因子的结肠靶向纳米纤维膜及其制备方法和应用 | |
CN111214441B (zh) | 一种古罗糖醛酸低聚糖脂质体及其制备方法 | |
CN107868805B (zh) | 一种通过乳酸菌发酵降解的龙眼多糖及其制备方法 | |
Li et al. | Preparation and characterization of zein-tannic acid nanoparticles/chitosan composite films and application in the preservation of sugar oranges | |
Yuan et al. | Janus biopolymer nanocomposite coating with excellent antibacterial and water/oxygen barrier performance for fruit preservation | |
CN109691672A (zh) | 一种包封游离虾青素的脂质体及其制备方法 | |
Liu et al. | Silk fibroin scavenges hydroxyl radicals produced from a long-term stored water-soluble fullerene system | |
Lin et al. | Controllable preparation of bioactive open porous microspheres for tissue engineering | |
CN112957266B (zh) | 一种花生油体膜蛋白修饰的脂质体及其制备方法 | |
CN112891559B (zh) | 促进牙髓干细胞增殖和成骨分化的多肽共修饰柚皮苷纳米脂质体及其制备方法和用途 | |
CN104127386B (zh) | 一种大叶茜草素/壳聚糖纳米微球及其制备方法和应用 | |
Liu et al. | A biomimetic strategy for controllable degradation of chitosan scaffolds | |
CN109628524A (zh) | 增强羊栖菜多糖生物活性的方法 | |
CN108641997A (zh) | 一种多孔plga微载体及其制备方法和应用 | |
CN109136307B (zh) | 一种用蜗牛酶制备壳寡糖的方法及其用途 | |
CN116042422A (zh) | 一种酵母来源外泌体及其制备方法和应用 | |
CN109364029A (zh) | 一种白藜芦醇微球及其制备方法 | |
JP6722939B2 (ja) | 免疫賦活化組成物 | |
CN102443151B (zh) | PCL-Tween 80共聚物及其制备方法与应用 | |
LU505016B1 (en) | An amphiphilic xylan polymer, preparation method therefor and application thereof in pesticide | |
CN114931588B (zh) | 银纳米粒卡那霉素抗菌水凝胶的制备方法 | |
CN115305230B (zh) | 脂多糖诱导的Caco-2/RAW264.7细胞共培养模型的建立方法及应用 | |
CN111909693B (zh) | 一种明胶碳点及其制备方法和应用 | |
CN115400045B (zh) | 一种维生素c柔性脂质体及其制备方法和应用 | |
Yang et al. | Encapsulation, characterization and in vitro releasing of xylanase and glucose oxidase (GOD) into cellulose nanocrystals stabilized three-layer microcapsules |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20200602 Assignee: Qingdao Dongfang Divine Machinery Co.,Ltd. Assignor: SHENZHEN University Contract record no.: X2022980024343 Denomination of invention: A kind of guturonic acid oligosaccharide liposome and its preparation method Granted publication date: 20210608 License type: Common License Record date: 20221201 |
|
EE01 | Entry into force of recordation of patent licensing contract | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20200602 Assignee: Shenzhen Dongfang Renshou Life Technology Co.,Ltd. Assignor: SHENZHEN University Contract record no.: X2022980025926 Denomination of invention: A kind of guturonic acid oligosaccharide liposome and its preparation method Granted publication date: 20210608 License type: Common License Record date: 20221211 |
|
EE01 | Entry into force of recordation of patent licensing contract | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20200602 Assignee: Guangdong Tianzhuang Cosmetics Co.,Ltd. Assignor: SHENZHEN University Contract record no.: X2023980030950 Denomination of invention: Gurosuronic acid oligosaccharide liposome and its preparation method Granted publication date: 20210608 License type: Common License Record date: 20230116 |
|
EE01 | Entry into force of recordation of patent licensing contract |